Spain lacked prominence in the development of the first vaccines against Covid in 2020, but that does not mean that our laboratories renounced such an important scientific challenge.
This is demonstrated by the Hipra drug which, far from being a replica of the existing antidotes, includes important improvements.
From a logistical and economic point of view, the possibility of storing this vaccine at temperatures typical of any domestic refrigerator is a great advance. But even more important is the possibility of modifying its active principles in a matter of months to respond to Covid mutations.
This is a first-rate added value considering the danger posed by the new Lambda variant of the virus.
Spain lacked prominence in the development of the first vaccines against Covid in 2020, but that does not mean that our laboratories renounced such an important scientific challenge.
This is demonstrated by the Hipra drug which, far from being a replica of the existing antidotes, includes important improvements.
From a logistical and economic point of view, the possibility of storing this vaccine at temperatures typical of any domestic refrigerator is a great advance. But even more important is the possibility of modifying its active principles in a matter of months to respond to Covid mutations.
This is a first-rate added value considering the danger posed by the new Lambda variant of the virus.
